FLASH SPRING SALE: 50% Off Premium Subscription >> FLASH SPRING SALE: 50% Off Premium >>
$0.759
+0.0067 (+0.89%)
At Close: May 01, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.631 $0.95 Wednesday, 1st May 2024 CARA stock ended at $0.759. This is 0.89% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 7.53% from a day low at $0.723 to a day high of $0.777.
90 days $0.515 $1.15
52 weeks $0.500 $4.67

Historical Cara Therapeutics prices

Date Open High Low Close Volume
Dec 09, 2021 $12.67 $12.95 $12.35 $12.37 430 168
Dec 08, 2021 $12.82 $13.03 $12.59 $12.80 317 219
Dec 07, 2021 $12.22 $12.95 $12.22 $12.74 477 963
Dec 06, 2021 $12.31 $12.50 $12.04 $12.14 425 602
Dec 03, 2021 $12.90 $13.02 $12.22 $12.31 499 775
Dec 02, 2021 $12.61 $12.91 $12.39 $12.89 704 158
Dec 01, 2021 $13.30 $13.32 $12.61 $12.61 688 108
Nov 30, 2021 $13.00 $13.40 $12.70 $13.18 919 732
Nov 29, 2021 $12.95 $13.23 $12.54 $12.58 507 214
Nov 26, 2021 $13.25 $13.30 $12.49 $12.80 510 563
Nov 24, 2021 $13.26 $13.46 $13.06 $13.34 521 643
Nov 23, 2021 $13.58 $13.92 $13.24 $13.44 940 034
Nov 22, 2021 $14.16 $14.45 $13.50 $13.63 728 116
Nov 19, 2021 $14.40 $14.72 $14.15 $14.18 636 416
Nov 18, 2021 $14.86 $14.99 $14.12 $14.44 726 385
Nov 17, 2021 $15.20 $15.48 $14.78 $14.84 721 755
Nov 16, 2021 $15.50 $15.64 $15.11 $15.32 567 031
Nov 15, 2021 $16.13 $16.28 $15.43 $15.64 537 665
Nov 12, 2021 $16.30 $16.58 $15.93 $16.25 460 870
Nov 11, 2021 $16.93 $17.39 $16.16 $16.17 550 381
Nov 10, 2021 $17.77 $18.60 $16.54 $16.56 906 893
Nov 09, 2021 $17.23 $18.93 $17.23 $18.14 1 269 486
Nov 08, 2021 $17.81 $17.99 $17.16 $17.23 543 243
Nov 05, 2021 $17.63 $18.28 $17.30 $17.89 711 599
Nov 04, 2021 $17.20 $17.87 $16.86 $17.65 594 999
Click to get the best stock tips daily for free!

About Cara Therapeutics

Cara Therapeutics Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of mod... CARA Profile

Golden Star

Ticker Date Change Price
ETSY Apr 26 1.84% $67.43
DHT Apr 24 1.24% $11.28
LPLA Apr 19 2.49% $262.59
MLI Apr 19 6.77% $52.28
PFLT Apr 18 1.07% $11.25
DOOR Apr 18 0.88% $131.39
LNG Apr 17 0.644% $156.81
FCN Apr 16 2.99% $207.62
ELV Apr 16 4.26% $506.97
ITCI Apr 05 4.92% $68.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT